These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 16444795)

  • 21. Mirtazapine in the treatment of adolescents with major depression: an open-label, multicenter pilot study.
    Haapasalo-Pesu KM; Vuola T; Lahelma L; Marttunen M
    J Child Adolesc Psychopharmacol; 2004; 14(2):175-84. PubMed ID: 15319015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.
    Varia I; Venkataraman S; Hellegers C; Gersing K; Doraiswamy PM
    Psychopharmacol Bull; 2007; 40(1):47-56. PubMed ID: 17285095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of antidepressant mirtazapine on fibromyalgia symptoms.
    Samborski W; Lezańska-Szpera M; Rybakowski JK
    Rocz Akad Med Bialymst; 2004; 49():265-9. PubMed ID: 15631355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal.
    Cruickshank CC; Montebello ME; Dyer KR; Quigley A; Blaszczyk J; Tomkins S; Shand D
    Drug Alcohol Rev; 2008 May; 27(3):326-33. PubMed ID: 18368615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine-mirtazapine combination in the treatment of persistent depressive illness.
    Hannan N; Hamzah Z; Akinpeloye HO; Meagher D
    J Psychopharmacol; 2007 Mar; 21(2):161-4. PubMed ID: 17329295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder: a randomized, open-labeled trial.
    Kang EH; Lee IS; Chung SK; Lee SY; Kim EJ; Hong JP; Oh KS; Woo JM; Kim S; Park JE; Yu BH
    Psychiatry Res; 2009 Sep; 169(2):118-23. PubMed ID: 19695711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open-label study of mirtazapine as treatment for combat-related PTSD.
    Alderman CP; Condon JT; Gilbert AL
    Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A; Richard C; Prinzo R; Binder C
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous mirtazapine is safe and effective in the treatment of depressed inpatients.
    Mühlbacher M; Konstantinidis A; Kasper S; Eichberger G; Hinterhuber H; Hofmann P; Nimmerrichter A; Schubert H; Egger C; Nickel M; Stuppaeck C
    Neuropsychobiology; 2006; 53(2):83-7. PubMed ID: 16511339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mirtazapine-induced manic switch in adolescent unipolar depression.
    Goyal N; Sinha VK
    Aust N Z J Psychiatry; 2008 Dec; 42(12):1070-1. PubMed ID: 19031640
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients.
    Schüle C; Baghai TC; Eser D; Schwarz M; Bondy B; Rupprecht R
    J Psychiatr Res; 2009 Feb; 43(5):538-45. PubMed ID: 18706658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial.
    Berk M; Gama CS; Sundram S; Hustig H; Koopowitz L; D'Souza R; Malloy H; Rowland C; Monkhouse A; Monkhouse A; Bole F; Sathiyamoorthy S; Piskulic D; Dodd S
    Hum Psychopharmacol; 2009 Apr; 24(3):233-8. PubMed ID: 19330802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysthymic disorder: treatment with mirtazapine.
    Dunner DL; Hendrickson HE; Bea C; Budech CB; O'Connor E
    Depress Anxiety; 1999; 10(2):68-72. PubMed ID: 10569129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and tolerability of mirtazapine and amitriptyline in alcoholic patients with co-morbid depressive disorder: a randomized, double-blind study.
    Altintoprak AE; Zorlu N; Coskunol H; Akdeniz F; Kitapcioglu G
    Hum Psychopharmacol; 2008 Jun; 23(4):313-9. PubMed ID: 18327889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G; Hennig J; Baghai T; Schüle C
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly.
    Fox CB; Treadway AK; Blaszczyk AT; Sleeper RB
    Pharmacotherapy; 2009 Apr; 29(4):383-97. PubMed ID: 19323618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.